B
Braidwell Portfolio holdings
AUM
$3.37B
1-Year Est. Return
0.13%
1 Year Est. Return
+0.13%
AUM
$3.37B
AUM Growth
+$446M
(+15%)
Holding
80
Top Buys
| 1 | +$86.7M | |
| 2 | +$50.8M | |
| 3 | +$44.7M | |
| 4 |
CVS Health
CVS
|
+$33.1M |
| 5 |
Dianthus Therapeutics
DNTH
|
+$32.9M |
Top Sells
| 1 | +$87.3M | |
| 2 | +$46.8M | |
| 3 | +$43.6M | |
| 4 |
Neurocrine Biosciences
NBIX
|
+$39.3M |
| 5 |
Krystal Biotech
KRYS
|
+$36.6M |
Sector Composition
| 1 | Healthcare | 73.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CAI
1
Caris Life Sciences
CAI
$7.35B
| $221M | 6.57% |
7,316,142
|
|
||
2
Xenon Pharmaceuticals
XENE
$3.36B
| $145M | 4.29% |
3,605,029
|
|
||
3
CG Oncology
CGON
$3.49B
| $132M | 3.92% |
3,283,317
|
|
||
|
4
Neurocrine Biosciences
NBIX
$15B
| $124M | 3.67% |
880,282
-280,143
|
|
||
|
5
Krystal Biotech
KRYS
$6.24B
| $91.9M | 2.73% |
520,401
-207,410
|
|
||
6
Nuvalent
NUVL
$8.26B
| $87.6M | 2.6% |
1,012,982
-162,894
|
|
||
7
Soleno Therapeutics
SLNO
$2.63B
| $86.7M | 2.57% |
+1,281,989
|
|
||
8
Edgewise Therapeutics
EWTX
$2.67B
| $84.5M | 2.51% |
5,210,831
|
|
||
9
Inspire Medical Systems
INSP
$3.67B
| $65.6M | 1.95% |
883,747
+361,337
|
|
||
10
Glaukos
GKOS
$6.1B
| $63.6M | 1.89% |
780,164
+176,750
|
|
||
11
Danaher
DHR
$158B
| $61.3M | 1.82% |
309,339
|
|
||
12
Legend Biotech
LEGN
$4.96B
| $59.6M | 1.77% |
1,826,155
-715,949
|
|
||
13
Intuitive Surgical
ISRG
$201B
| $58.2M | 1.73% |
130,227
+40,627
|
|
||
14
Apogee Therapeutics
APGE
$4.71B
| $57.2M | 1.7% |
1,438,745
-39,767
|
|
||
15
argenx
ARGX
$55.1B
| $56.1M | 1.67% |
76,091
-118,400
|
|
||
16
Thermo Fisher Scientific
TMO
$220B
| $55.3M | 1.64% |
113,933
-21,300
|
|
||
17
Align Technology
ALGN
$10.5B
| $51.3M | 1.52% |
409,691
-87,039
|
|
||
18
Acadia Pharmaceuticals
ACAD
$4.21B
| $50.8M | 1.51% |
+2,378,655
|
|
||
|
HNGE
19
Hinge Health
HNGE
$3.78B
| $44.7M | 1.33% |
+910,476
|
|
||
20
Spyre Therapeutics
SYRE
$2.22B
| $43.2M | 1.28% |
2,578,404
|
|
||
21
Transmedics
TMDX
$5.14B
| $39.4M | 1.17% |
351,248
+96,200
|
|
||
22
iRhythm Technologies
IRTC
$5.89B
| $38.8M | 1.15% |
225,845
-74,184
|
|
||
23
Penumbra
PEN
$11.4B
| $35.9M | 1.06% |
141,528
+11,900
|
|
||
24
Dyne Therapeutics
DYN
$2.94B
| $34.5M | 1.02% |
2,730,481
-542,868
|
|
||
|
25
CVS Health
CVS
$100B
| $33.1M | 0.98% |
+438,600
|
|